Rise Therapeutics Llc

This early-stage study is testing whether adding an oral probiotic (R-5780) to standard immunotherapy is safe for people with advanced solid tumors. The main goal is to see if the probiotic causes side effects and how it affects patients' quality of life. Researchers will also ch…

This early-stage study is testing the safety and effects of an oral probiotic called R-3750 in adults with mild to moderate ulcerative colitis. Researchers will monitor side effects and check if the probiotic reduces bowel inflammation and improves symptoms. The goal is to see if…

This early-stage study is testing the safety and effects of an oral probiotic called R-2487 in adults with active rheumatoid arthritis. Researchers will monitor 73 participants for side effects while measuring changes in their arthritis symptoms and inflammation levels. The study…